Book a meeting
DO-BO

Can Innovative Contracting Turn High‑Cost Therapies into Sustainable Deals, Omar Ali?

In this thought‑provoking Market Access Podcast episode, host Stefan Walzer sits down with Omar Ali – Head of Payers at Vipora, former NICE advisor, and one of the sharpest minds in drug pricing and innovative contracting to unpack where drug pricing and reimbursement are really heading. 

They explore why cost‑effectiveness thresholds are making market access tougher than ever, how uncertainty around CAR‑T, gene therapies and orphan drugs fuels the “orphan bubble”, how innovative contracting and pay‑for‑performance can (sometimes) rescue multi‑million‑euro therapies and why the US is doing HTA at the end, not the beginning – with CMS negotiations, MFN and tariffs reshaping global pricing strategies. 

If you work in Market Access, pricing, Health Economics and Outcomes Research (HEOR) or policy, this conversation will resonate with the pressures you feel every day.

Related

What Makes Australia’s HTA Approach to Equity and Health Productivity Unique, Zanfina Ademi?

By

Stefan Walzer

In this Market Access Podcast episode, Dr. Stefan Walzer sits down with Prof. Zanfania Ademi, a health economist at Monash University, to explore how Australia’s healthcare system is tackling key issues in market access and health technology assessment. Discover how Australia blends international approaches and new methods being developed by Zanfina and her team like […]

No Decisions for Us, Without Us: Why Patient Advocacy Matters in Market Access, Erica Bersin?

By

Stefan Walzer

In this episode of the Market Access Podcast, Erica Bersin – founder of ERO Health Communications – joins Dr. Stefan Walter to discuss the changing role of patient involvement in healthcare. Drawing on her experience in both Europe and the U.S., Erica explains how single-payer systems make patient engagement easier, while the U.S. faces more […]

Can VR and AR Finally Break Through the Barriers in Medical Innovation, Günther Illert?

By

Stefan Walzer

In this episode of the Market Access Podcast, Dr. Stefan Walzer sits down with strategy consultant and XR advocate Günther Illert to explore how virtual, augmented, and extended reality are reshaping healthcare—from patient training and pain therapy to surgical planning and medtech education. Learn how cross-sector collaboration and early adoption—especially outside traditional reimbursement systems—can unlock […]